2024    2023    2022    2021    2020    2019    2018    2017    2016   

2020

Articles

11 - 

Chimeric antigen receptor (CAR) T-cells on the march from diffuse large B-cell lymphoma to mantle cell lymphoma

Roch Houot, Philippe Armand, Caron A Jacobson

European Journal of Cancer, 2020, 131, pp.51-52.

DOI : https://doi.org/10.1016/j.ejca.2020.03.001

Pubmed : 32283478

 

12 - 

Total immunotherapy for Hodgkin lymphoma

Roch Houot, Reid W. Merryman, Franck Morschhauser

Lancet Haematology, 2020, 7 (9), pp.e629-e630.

DOI : https://doi.org/10.1016/S2352-3026(20)30220-9

Pubmed : 32853579

 

13 - 

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?

Roch Houot, Ronald Levy, Guillaume Cartron, Philippe Armand

European Journal of Cancer, 2020, 136, pp.4-6.

DOI : https://doi.org/10.1016/j.ejca.2020.06.017

Pubmed : 32619884

 

14 - 

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers

Thomas Hueso, T. Gastinne, Sylvain Garciaz, Emmanuelle Tchernonog, Caroline Delette, René-Olivier Casasnovas, Eric Durot, Roch Houot, Benoit Tessoulin, Olivier Tournilhac et al.

Bone Marrow Transplantation, 2020, 55 (6), pp.1076-1084.

DOI : https://doi.org/10.1038/s41409-020-0783-y

Pubmed : 31953532

 

15 - 

Upper body lift and breast reshaping with lateral chest wall perforator propeller flap following massive weight loss

N Isola, C Herlin, B Chaput, S Aillet, E Watier, N B.ertheuil

Annales de Chirurgie Plastique Esthétique, 2020, 65 (1), pp.44-53.

DOI : https://doi.org/10.1016/j.anplas.2019.07.006

Pubmed : 31350099

 

16 - 

First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20 Non-Hodgkin Lymphomas

Ajay K Gopal, Ronald Levy, Roch Houot, Sandip P Patel, Leslie Popplewell, Caron Jacobson, Xinmeng J Mu, Shibing Deng, Keith A Ching, Ying Chen et al.

Clinical Cancer Research, 2020, 26 (11), pp.2524-2534.

DOI : https://doi.org/10.1158/1078-0432.CCR-19-2973

Pubmed : 32144134

 

17 - 

Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer

Yann Kieffer, Hocine Rachid Hocine, Géraldine Gentric, Floriane Pelon, Charles Bernard, Brigitte Bourachot, Sonia Lameiras, Luca Albergante, Claire Bonneau, Alice Guyard et al.

Cancer Discovery, 2020, 10 (9), pp.1330-1351.

DOI : https://doi.org/10.1158/2159-8290.CD-19-1384

Pubmed : 32434947

 

18 - 

Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group

Steven Le Gouill, Asma Beldi-Ferchiou, Marion Alcantara, Victoria Cacheux, Violaine Safar, Barbara Burroni, Stéphanie Guidez, Thomas Gastinne, Danielle Canioni, Catherine Thieblemont et al.

Lancet Haematology, 2020, 7 (11), pp.e798-e807.

DOI : https://doi.org/10.1016/S2352-3026(20)30291-X

Pubmed : 32971036

 

19 - 

Definition of B cell helper T cells in rheumatoid arthritis and their behavior during treatment

C. Lucas, A. Perdriger, P. Amé

Seminars in Arthritis and Rheumatism, 2020, 50 (5), pp.867-872.

DOI : https://doi.org/10.1016/j.semarthrit.2020.06.021

Pubmed : 32896702

 

20 - 

Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation

Guillaume Manson, Pauline Brice, Charles Herbaux, Kamal Bouabdallah, Chloé Antier, Florence Poizeau, Laurent Dercle, Roch Houot

Haematologica, 2020, 105 (11), pp.2664-2666.

DOI : https://doi.org/10.3324/haematol.2019.242529

Pubmed : 33131257